Marker Therapeutics EPS Basic from Tax Loss Carryforward (Quarterly) Analysis

Marker Therapeutics, Inc. (MRKR)

2.18 +0.06 (+2.83%) USD | NASDAQ | Jan 21, 16:00

2.18 0.00 (0.00%) After-Hours: 20:00

View EPS Basic from Tax Loss Carryforward (Quarterly) for MRKR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Tax Loss Carryforward (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Tax Loss Carryforward (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Tax Loss Carryforward (Quarterly) Benchmarks

Start Trial

Viridian Therapeutics, Inc.	--
ADMA Biologics, Inc.	--
Kiniksa Pharmaceuticals International Plc	--
Neurocrine Biosciences, Inc.	--
AIM ImmunoTech, Inc.	--